Trials / Unknown
UnknownNCT02384291
Sinus Floor Elevation Using Alpha-Bio's GRAFT Natural Bovine Bone vs. Commercially Available Bone Graft
Sinus Floor Elevation Using Alpha-Bio's GRAFT Natural Bovine Bone Versus Commercially Available Bone Graft. A Prospective Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Alpha - Bio Tec Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study is designed to compare the regenerative outcome of using separately two different Xenografts during sinus floor augmentation. Aim of this prospective randomized-controlled clinical trial is to compare the regenerative results of Alpha-Bio's GRAFT Natural Bovine Bone versus commercially available bone graft after two-step sinus floor elevations by clinical and histological analysis. Clinical Parameters are wound healing parameters, radiological volume stability and implant survival rates. Histological parameters are based on a histomorphometrical analysis of trephine cores harvested in progress of implant bed preparation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Alpha-Bio GRAFT Natural Bovine Bone | Pure Hydroxyapatite ceramic mineral with high similarity to the human bone |
| DEVICE | natural bone substitute | natural bone substitute material derived from the mineral portion of bovine bone |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2019-12-01
- Completion
- 2020-06-01
- First posted
- 2015-03-10
- Last updated
- 2019-07-16
Source: ClinicalTrials.gov record NCT02384291. Inclusion in this directory is not an endorsement.